Biomarin Pharmaceutical (BMRN) Net Income (2009 - 2026)
Biomarin Pharmaceutical (BMRN) reported Net Income of $44.76 million for Q2 2026, down 81.4% from $240.53 million a year earlier and down 57.6% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Net Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biomarin Pharmaceutical's Net Income came in at $72.97 million, down 88.9% year-over-year; for FY2025, it was $348.9 million, down 18.3% from FY2024.
- Net Income has a five-year compound annual growth rate of -16.4% (FY2020 to FY2025).
- By year, Net Income came in at $426.86 million in FY2024 (+154.6%), $167.65 million in FY2023 (+18.4%), $141.56 million in FY2022 and -$64.08 million in FY2021.
- Five-year quarterly Net Income spans a low of -$57.9 million in Q4 2021 and a high of $240.53 million in Q2 2025.
- Year over year, Net Income gained in four of the last six quarters, with growth averaging 130.9%.
- The high point for year-over-year Net Income in five years was Q1 2022 (growth of 595.4%); the low point was Q2 2026 (a decline of 81.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $105.53 million (Q1 2026), -$46.57 million (Q4 2025) and -$30.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | 44.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.76 Mn |
| Mar 31, 2026 | 105.53 Mn |
| Dec 31, 2025 | -46.57 Mn |
| Sep 30, 2025 | -30.74 Mn |
| Jun 30, 2025 | 240.53 Mn |
| Mar 31, 2025 | 185.69 Mn |
| Dec 31, 2024 | 124.94 Mn |
| Sep 30, 2024 | 106.08 Mn |
| Jun 30, 2024 | 107.17 Mn |
| Mar 31, 2024 | 88.66 Mn |
| Dec 31, 2023 | 20.38 Mn |
| Sep 30, 2023 | 40.38 Mn |
| Jun 30, 2023 | 56.04 Mn |
| Mar 31, 2023 | 50.85 Mn |
| Dec 31, 2022 | -249,000.00 |
| Sep 30, 2022 | -6.65 Mn |
| Jun 30, 2022 | 27.66 Mn |
| Mar 31, 2022 | 120.80 Mn |
| Dec 31, 2021 | -57.90 Mn |
| Sep 30, 2021 | -36.49 Mn |
API Access
Biomarin Pharmaceutical Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();